Skip to main content
Signal8

Fisher Andrew

SEC insider (Form 3/4/5 filer). CIK 0002014301. General Counsel at Verona Pharma plc (VRNA). 19 reported Form 4/5 transactions since Sep 2024; latest on Oct 7, 2025. Located in LONDON, X0.

Companies Fisher Andrew has filed insider reports for

  • Verona Pharma plc (VRNA): Officer, General Counsel
Fisher Andrew profile photo

Fisher Andrew

CIK: 0002014301

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (21.1%)

Position reduction

Option Exercises (M)7 (36.8%)

Derivative conversions

Awards (A)4 (21.1%)

Compensation grants

Other (G, F, J, C, D, …)4 (21.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Verona Pharma plc logo
VRNA

Verona Pharma plc

Officer

Discretionary Trading P&L

Holdings

Transaction History (19 total)

  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Disposition
    Direct
    417.9K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Exercise
    Direct
    932K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Disposition
    Direct
    932K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Award

    Restricted Share Unit

    Direct
    618.8K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Aug 1, 2025
    Exercise
    Direct
    20.9K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Aug 1, 2025
    Sale
    Direct
    9.6K shares at avg. $13.14$126K
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Jul 8, 2025
    Tax Payment
    Direct
    39.5K shares at avg. $11.44$452K
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Jul 7, 2025
    Award

    Restricted Share Units

    Direct
    253.1K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Jul 7, 2025
    Exercise
    Direct
    86.1K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Jun 16, 2025
    Sale
    Direct
    80K shares at avg. $11.53$922K

1-10 of 19